Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management

Author： Garvey William Timothy  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.5, 2013-09, pp. : 741-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fixed-dose combination of phentermine-topiramate for the treatment of obesity

By Halpern Bruno   Faria André M   Halpern Alfredo  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 3, 2013-05 ,pp. : 235-241

Informa Healthcare

Access to resources Recommend Favorite

Topiramate/phentermine combination effective for obesity

By  

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Phentermine and Topiramate Extended Release (Qsymia™): First Global Approval

By Cameron Fiona  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 2033-2042

Adis International

Access to resources Recommend Favorite

Oxybutynin Extended-Release: A Review of its Use in the Management of Overactive Bladder

By Siddiqui M.A.A.   Perry C.M.   Scott L.J.  

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 885-912

Adis International

Access to resources Recommend Favorite

Venlafaxine Extended-Release: A Review of its Use in the Management of Major Depression

By Wellington K.   Perry C.M.  

CNS Drugs, Vol. 15, Iss. 8, 2001-01 ,pp. : 643-669

Adis International

Access to resources Recommend Favorite